Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
EML4-ALK Fusion as a Resistance Mechanism to Osimertinib and Its Successful Management With Osimertinib and Alectinib: Case Report and Review of the Literature
PaperCitations, authors & open-access status
EML4-ALK Fusion as a Resistance Mechanism to Osimertinib and Its Successful Management With Osimertinib and Alectinib: Case Report and Review of the Literature is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 25 citations, 2020 year and closed oa status.
25
Citations
2020
Year
closed
OA Status